Suppr超能文献

帕金森病的基因大鼠模型。

Genetic rat models of Parkinson's disease.

机构信息

Field Neurosciences Institute, Laboratory for Restorative Neurology, Department of Psychology, Central Michigan University, Mt. Pleasant, MI 48859, USA.

出版信息

Parkinsons Dis. 2012;2012:128356. doi: 10.1155/2012/128356. Epub 2012 Apr 5.

Abstract

Parkinson's disease (PD) is a neurodegenerative disease characterized by a specific loss of dopaminergic neurons. Although the vast majority of PD cases are idiopathic in nature, there is a subset that contains genetic links. Of the genes that have been linked to PD, α-synuclein and leucine-rich repeat kinase 2 have been used to develop transgenic rat models of the disease. In this paper we focused on the various transgenic rat models of PD in terms of their ability to mimic key symptoms of PD in a progressive manner. In general, we found that most of these models provided useful tools for the early stages of PD, but the development of new transgenic rats that present significant neuropathologic and motoric deficits in a progressive manner that more accurately mimics PD is needed.

摘要

帕金森病(PD)是一种神经退行性疾病,其特征是多巴胺能神经元的特定丧失。尽管绝大多数 PD 病例本质上是特发性的,但有一部分病例包含遗传联系。在与 PD 相关的基因中,α-突触核蛋白和富含亮氨酸重复激酶 2 已被用于开发该疾病的转基因大鼠模型。在本文中,我们重点研究了各种 PD 转基因大鼠模型在逐渐模拟 PD 关键症状方面的能力。总的来说,我们发现这些模型中的大多数为 PD 的早期阶段提供了有用的工具,但需要开发新的转基因大鼠,这些大鼠以更准确地模拟 PD 的方式逐渐出现显著的神经病理学和运动缺陷。

相似文献

1
Genetic rat models of Parkinson's disease.
Parkinsons Dis. 2012;2012:128356. doi: 10.1155/2012/128356. Epub 2012 Apr 5.
2
New Developments in Genetic rat models of Parkinson's Disease.
Mov Disord. 2018 May;33(5):717-729. doi: 10.1002/mds.27296. Epub 2018 Feb 8.
6
Mitochondrial dysfunction in genetic animal models of Parkinson's disease.
Antioxid Redox Signal. 2012 May 1;16(9):896-919. doi: 10.1089/ars.2011.4200. Epub 2011 Oct 4.
9
Back and to the Future: From Neurotoxin-Induced to Human Parkinson's Disease Models.
Curr Protoc Neurosci. 2020 Mar;91(1):e88. doi: 10.1002/cpns.88.

引用本文的文献

1
Modeling of Parkinson's Disease in Different Models.
CNS Neurol Disord Drug Targets. 2025;24(2):102-114. doi: 10.2174/0118715273326866240922193029.
3
The neurobiological basis of cognitive impairment in Parkinson's disease.
Mov Disord. 2014 Apr 15;29(5):634-50. doi: 10.1002/mds.25857.
4
A Role for the Brain RAS in Alzheimer's and Parkinson's Diseases.
Front Endocrinol (Lausanne). 2013 Oct 25;4:158. doi: 10.3389/fendo.2013.00158.
5
Importance of the brain Angiotensin system in Parkinson's disease.
Parkinsons Dis. 2012;2012:860923. doi: 10.1155/2012/860923. Epub 2012 Nov 7.

本文引用的文献

1
Using stem cells and iPS cells to discover new treatments for Parkinson's disease.
Parkinsonism Relat Disord. 2012 Jan;18 Suppl 1(0 1):S14-6. doi: 10.1016/S1353-8020(11)70007-4.
3
GDNF fails to exert neuroprotection in a rat α-synuclein model of Parkinson's disease.
Brain. 2011 Aug;134(Pt 8):2302-11. doi: 10.1093/brain/awr149. Epub 2011 Jun 28.
4
Temporal expression of mutant LRRK2 in adult rats impairs dopamine reuptake.
Int J Biol Sci. 2011;7(6):753-61. doi: 10.7150/ijbs.7.753. Epub 2011 Jun 9.
8
Generation of a alpha-synuclein-based rat model of Parkinson's disease.
Neurobiol Dis. 2008 Apr;30(1):8-18. doi: 10.1016/j.nbd.2007.11.002. Epub 2007 Nov 13.
9
The phosphorylation state of Ser-129 in human alpha-synuclein determines neurodegeneration in a rat model of Parkinson disease.
Proc Natl Acad Sci U S A. 2008 Jan 15;105(2):763-8. doi: 10.1073/pnas.0711053105. Epub 2008 Jan 4.
10
LRRK2 mutations are a common cause of Parkinson's disease in Spain.
Eur J Neurol. 2006 Apr;13(4):391-4. doi: 10.1111/j.1468-1331.2006.01256.x.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验